The ratings assignment is based on a number of factors, including the health system’s material cash flow losses and liquidity declines.
The ratings agency also affirmed the “Caa1” and “Caa1/SG” ratings on GSHS’s outstanding series 2015A bonds, affecting $145 million of debt.
The outlook was revised to stable from negative, reflecting Moody’s Investors Service’s expectation GSHS’s merger with Irving, Texas-based Christus Health will have lasting management and financial benefits and will reduce acceleration risk in the near-term following expected waiver of financial covenants.
More articles on healthcare finance:
Fitch upgrades New York City Health + Hospitals’ rating to ‘AA-‘
Moody’s assigns ‘MIG1’ rating to South Central Regional Medical Center’s notes
S&P revises Massachusetts Ear and Eye’s outlook to negative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
